Atlas Legacy Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$756K Sell
3,101
-1,049
-25% -$244K 0.14% 106
2025
Q4
$872K Buy
4,150
+49
+1% +$9.69K 0.15% 99
2025
Q3
$760K Buy
4,101
+1,366
+50% +$234K 0.15% 99
2025
Q2
$418K Buy
2,735
+463
+20% +$71.2K 0.09% 130
2025
Q1
$377K Buy
2,272
+535
+31% +$83.7K 0.1% 126
2024
Q4
$251K Buy
+1,737
New +$269K 0.06% 156

Other funds holding JNJ

Atlas Legacy Advisors's JNJ Position: Q1 2026 in Review

Atlas Legacy Advisors reduced its Johnson & Johnson (JNJ) stake by 25% in Q1 2026, selling an estimated $244K and leaving 3,101 shares worth $756K. The position accounts for 0.14% of the portfolio, ranked #106.

Atlas Legacy Advisors first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. The position peaked at $872K in Q4 2025. 4,612 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Atlas Legacy Advisors held 3,101 shares of Johnson & Johnson worth $756K as of Q1 2026.
  • Atlas Legacy Advisors sold 1,049 Johnson & Johnson shares in Q1 2026, an estimated $244K.
  • Johnson & Johnson made up 0.14% of Atlas Legacy Advisors's portfolio in Q1 2026, its #106 holding.
  • Atlas Legacy Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • Atlas Legacy Advisors's Johnson & Johnson position peaked at $872K in Q4 2025.
  • 4,612 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Atlas Legacy Advisors's 13F filing for Q1 2026, filed 11 May 2026.